Zerion Pharma and Hovione form strategic partnership to market and commercialise the proprietary Dispersome® technology platform
February 22, 2022 (COPENHAGEN, Denmark). Zerion Pharma A/S (ZERION), a Danish drug development company, is pleased to announce today to have entered into a strategic partnership with HOVIONE, a leading global specialist integrated development and contract manufacturer to accelerate the commercialization of the Dispersome® technology pioneered by ZERION.Through their partnership, HOVIONE and ZERION are offering pharma and biotech companies worldwide access to an innovative drug delivery platform combined with an unparalleled experience in formulation development, scale up and GMP